A Study of Combination With TBI-1401(HF10) and Ipilimumab in Japanese Patients With Unresectable or Metastatic Melanoma
Status:
Completed
Trial end date:
2018-12-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if TBI-1401(HF10) in combination with ipilimumab is
effective in Japanese patients with stages IIIB, IIIC, or IV unresectable or metastatic
melanoma.